Watertown, MA, United States of America

Mark Grier

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Cambridge, MA (US) (2008)
  • Watertown, MA (US) (2010 - 2013)
  • Medford, MA (US) (2016)
  • Midvale, UT (US) (2017)

Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mark Grier: Innovator in Tetracycline Compounds

Introduction

Mark Grier, an accomplished inventor based in Watertown, MA, has made significant contributions to the field of pharmaceuticals with a particular focus on tetracycline compounds. With a total of five patents to his name, Grier’s work addresses critical health issues, including bacterial infections and cancer-related conditions.

Latest Patents

Among his latest patents are two notable inventions: the first involves novel substituted tetracycline compounds, which present exciting possibilities for treating a range of tetracycline-responsive states, such as bacterial infections and neoplasms. By blocking tetracycline efflux and modulating gene expression, these compounds offer innovative therapeutic avenues. The second patent details methods for synthesizing these substituted tetracycline compounds, providing essential techniques to create these novel substances efficiently.

Career Highlights

Mark Grier is currently associated with Paratek Pharmaceuticals, Inc., a company renowned for its dedication to developing innovative antibacterial treatments. His role at Paratek has allowed him to leverage his expertise in medicinal chemistry and contribute significantly to the advancement of new therapeutic solutions.

Collaborations

Throughout his career, Grier has worked closely with talented colleagues such as Beena Bhatia and Todd Bowser. Their collaborative efforts within the research environment at Paratek Pharmaceuticals have further propelled innovations in the pharmaceutical landscape.

Conclusion

With a strong patent portfolio and ongoing research contributions, Mark Grier exemplifies the spirit of innovation. His work with tetracycline compounds not only paves the way for future medical advancements but also positions him as a vital player in the fight against bacterial and cancerous diseases. As pharmaceutical science continues to evolve, the impact of his inventions is likely to resonate in both clinical applications and research methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…